Bioceres Crop Solutions Corp. (BIOX)

NASDAQ: BIOX · Real-Time Price · USD
0.4290
-0.0204 (-4.54%)
At close: May 15, 2026, 4:00 PM EDT
0.4200
-0.0090 (-2.10%)
After-hours: May 15, 2026, 7:55 PM EDT
Market Cap27.23M -90.1%
Revenue (ttm)255.21M -33.4%
Net Income-247.25M
EPS-3.88
Shares Out 63.48M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume146,741
Open0.4433
Previous Close0.4494
Day's Range0.4268 - 0.4765
52-Week Range0.34715 - 5.1750
Beta0.39
AnalystsBuy
Price Target4.33 (+909.32%)
Earnings DateMay 11, 2026

About BIOX

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, comm... [Read more]

Sector Materials
Founded 2001
Employees 751
Stock Exchange NASDAQ
Ticker Symbol BIOX
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for BIOX stock is "Buy." The 12-month stock price target is $4.33, which is an increase of 909.32% from the latest price.

Price Target
$4.33
(909.32% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Bioceres Crop Solutions Earnings Call Transcript: Q3 2026

Fiscal Q3 2026 saw a 23% revenue decline and a $10 million net loss, driven by lower gross profit and the impact of the ProFarm foreclosure, which resulted in a $179 million non-cash loss. Management is focused on liquidity, legal disputes, and streamlining operations.

4 days ago - Transcripts

Bioceres reports Q3 operating profit $4.3M vs. ($4.3M) last year

Reports Q3 revenue $39.4M, one estimate $54.5M. Mr. Federico Trucco, Bioceres (BIOX)’ Chief Executive Officer, commented: “This quarter reflects a period of transition and operational refocusing for t...

5 days ago - TheFly

Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricul...

5 days ago - Business Wire

CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--The dial-in details of release dated May 4, 2026 have been revised. The US Toll Free dial-in number should read 1-833-461-5787; the International dial-in numbers l...

11 days ago - Business Wire

Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to...

12 days ago - Business Wire

A Message from Our Chief Executive Officer

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX): Dear Fellow Shareholders, This communication accompanies the filing of our Form 6-K for the second quarter of fiscal ...

2 months ago - Business Wire

Bioceres price target lowered to $2 from $2.25 at Canaccord

Canaccord analyst Austin Moeller lowered the firm’s price target on Bioceres (BIOX) to $2 from $2.25 and keeps a Hold rating on the shares. On December 18, New York’s Supreme…

4 months ago - TheFly

Bioceres announces appointment of Ezequiel Simmermacher as CFO

Bioceres (BIOX) Crop Solutions announced the appointment of its Chief Financial Officer and changes to the composition of the board of directors of the company. Ezequiel Simmermacher is being appointe...

4 months ago - TheFly

Bioceres price target lowered to $2.25 from $2.50 at Canaccord

Canaccord lowered the firm’s price target on Bioceres (BIOX) to $2.25 from $2.50 and keeps a Hold rating on the shares. The firm reported lower Q1 revenues and adjusted EBITDA.

6 months ago - TheFly

Bioceres Crop Solutions Earnings Call Transcript: Q1 2026

Revenue fell 17% year-over-year to $77.5 million, but gross margin expanded to 47% and adjusted EBITDA rose 61% due to cost reductions. Segment margins improved, though seed and crop protection revenues declined. Net debt remained stable amid ongoing debt dispute.

6 months ago - Transcripts

Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricul...

6 months ago - Business Wire

Bioceres Crop Solutions to Host Fiscal First Quarter 2026 Financial Results Conference Call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to...

7 months ago - Business Wire

Bioceres downgraded to Perform from Outperform at Oppenheimer

Oppenheimer downgraded Bioceres (BIOX) to Perform from Outperform without a price target The firm believes the company’s portfolio recapitalization “now appears incrementally challenging.” Bioceres is...

7 months ago - TheFly

Bioceres, Colorado Wheat Research Foundation team on HB4 wheat commercialization

Bioceres (BIOX) and the Colorado Wheat Research Foundation announced a strategic collaboration to jointly develop and commercialize HB4 wheat in the United States. The agreement combines Bioceres’ pro...

8 months ago - TheFly

Bioceres Crop Solutions and Colorado Wheat Research Foundation Partner to Advance Climate-Resilient HB4® Wheat in the U.S.

ROSARIO, Argentina & FORT COLLINS, Colorado--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) and the Colorado Wheat Research Foundation (CWRF) today announced a strategic collaboration t...

8 months ago - Business Wire

Bioceres price target lowered to $5 from $8 at Lake Street

Lake Street analyst Ben Klieve lowered the firm’s price target on Bioceres (BIOX) to $5 from $8 and keeps a Buy rating on the shares. Q4 results were materially below…

8 months ago - TheFly

Bioceres downgraded to Hold from Buy at Canaccord

Canaccord downgraded Bioceres (BIOX) to Hold from Buy with a price target of $2.50, down from $6.50. The company’s sales and adjusted EBITDA loss in fiscal Q4 were lower than…

8 months ago - TheFly

Bioceres Crop Solutions Earnings Call Transcript: Q4 2025

Fiscal 2025 saw a 28% revenue decline and margin compression due to macroeconomic headwinds in Argentina and a strategic shift in the seed business. Cost controls, working capital improvements, and international growth in core technologies are expected to support recovery and margin expansion as the company transitions to a more scalable model.

8 months ago - Transcripts

Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2025 Financial and Operational Results

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricul...

8 months ago - Business Wire

Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2025 Financial Results Conference Call on Tuesday, September 9, 2025 at 8:30 a.m. Eastern Time

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to...

9 months ago - Business Wire

Bioceres CFO Lopez Lecube steps down

In a regulatory filing yesterday, Bioceres (BIOX) Crop Solutions disclosed that the board of directors and Enrique Lopez Lecube, Chief Financial Officer, agreed to initiate a transition in the company...

9 months ago - TheFly

Bioceres downgraded to Hold from Buy at Brookline

Brookline downgraded Bioceres (BIOX) to Hold from Buy with a $26 price target The firm views the timing of the CFO’s departure as concerning.

9 months ago - TheFly

Bioceres Crop Solutions Announces Changes to Board of Directors

ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate ag...

11 months ago - Business Wire

Bioceres Crop Solutions Earnings Call Transcript: Q3 2025

Q3 saw a $40M year-over-year cash flow improvement despite lower revenues, driven by strategic seed business changes and working capital efficiency. RinoTec’s EPA approval and organizational restructuring position the company for growth, with positive outlooks in key markets.

1 year ago - Transcripts

Bioceres reports Q3 revenue $60.6M, consensus $61.87M

Federico Trucco, Bioceres (BIOX)’ CEO, commented: “Our third fiscal quarter is typically uneventful, as it falls in the off-season for most of our geographies. This year, however, it stands out…

1 year ago - TheFly